Family · Pharmaceutical analytical standards
Mosapride
A prokinetic that acts as a serotonin 5-HT4 receptor agonist, stimulating stomach and gut motility: approved in Japan in 1998 for the digestive symptoms of chronic gastritis. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is highly selective: it has no affinity for dopamine D2 receptors, unlike older prokinetics such as metoclopramide, nor for 5-HT1 and 5-HT2 receptors.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
